Reuters logo
BRIEF-As of March 31, Genkyotex cash & cash equivalents were EUR 21.8 million
April 27, 2017 / 5:44 PM / 7 months ago

BRIEF-As of March 31, Genkyotex cash & cash equivalents were EUR 21.8 million

April 27 (Reuters) - Genkyotex SA:

* Cash & cash equivalents of EUR 21.8 million ($23.7 million) as of March 31, 2017

* Is on track with the preparation for initiation of phase 2 trial with GKT831 in primary biliary cholangitis (PBC); trial expected to begin by end of h1 2017

* Cash position doesn’t include expected reimbursement of research tax credit for 2016, which co estimated to be at about EUR 3.0 million Source text for Eikon: Further company coverage: ($1 = 0.9196 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below